Do Not Give Two 1 mg ER Guanfacine Tablets to Achieve a 2 mg Dose
You should not substitute two 1 mg extended-release guanfacine tablets for a single 2 mg tablet, as guanfacine ER is available in pre-manufactured 2 mg tablets specifically designed for once-daily dosing, and splitting or doubling tablets may alter the extended-release mechanism and pharmacokinetic profile.
Why This Matters
The extended-release formulation of guanfacine is engineered as a specific delivery system. Guanfacine ER tablets come in 1,2,3, and 4 mg strengths 1. The extended-release matrix is designed to deliver the medication over 24 hours with once-daily administration 1.
Pharmacokinetic Concerns
The pharmacokinetics of immediate-release guanfacine differ substantially from guanfacine ER, making dose substitution on a milligram-for-milligram basis inappropriate 2. While the evidence specifically addresses IR versus ER formulations, the principle extends to altering the ER delivery system itself. Taking two 1 mg ER tablets simultaneously could potentially:
- Overwhelm the extended-release mechanism
- Create unpredictable plasma concentration peaks
- Alter the intended 24-hour coverage
- Increase risk of adverse effects related to higher peak concentrations
Proper Dosing Approach
The correct approach is straightforward:
- Use the commercially available 2 mg ER tablet as a single unit 1
- Administer once daily, adjusted to body weight (approximately 0.1 mg/kg as a rule of thumb) 1
- Doses are typically optimized between 1-4 mg/day based on efficacy and tolerability 1, 2
Safety Considerations
Guanfacine ER has specific cardiovascular effects including decreased heart rate and blood pressure 3. The extended-release formulation is designed to minimize peak-related adverse effects like somnolence, sedation, hypotension, and bradycardia 3, 1. Altering the delivery system by using multiple tablets could theoretically increase these risks.
Clinical Bottom Line
If a 2 mg dose is indicated, prescribe or dispense the 2 mg ER tablet. If only 1 mg tablets are available, contact the pharmacy or prescriber to obtain the appropriate strength rather than improvising with multiple tablets. The extended-release technology is integral to the medication's safety and efficacy profile, and should not be circumvented 2.